CA
AQST icon

Cliff Asness’s Aquestive Therapeutics AQST Stock Holding History

Cliff Asness’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$840K Buy
201,941
+150,347
+291% +$633K ﹤0.01% 3103
2026
Q1 		$214K Sell
51,594
-10,115
-16% -$41.1K ﹤0.01% 3571
2025
Q4 		$399K Buy
61,709
+3,934
+7% +$24.5K ﹤0.01% 3032
2025
Q3 		$323K Sell
57,775
-974
-2% -$4.21K ﹤0.01% 3053
2025
Q2 		$194K Sell
58,749
-70,270
-54% -$202K ﹤0.01% 3056
2025
Q1 		$374K Buy
129,019
+14,025
+12% +$42.5K ﹤0.01% 2583
2024
Q4 		$409K Sell
114,994
-15,806
-12% -$72.9K ﹤0.01% 2350
2024
Q3 		$651K Buy
+130,800
New +$509K ﹤0.01% 2059
2021
Q2 		– Sell
-19,786
Closed -$103K – 2219
2021
Q1 		$103K Hold
19,786
– – ﹤0.01% 2154
2020
Q4 		$106K Buy
19,786
+776
+4% +$4.65K ﹤0.01% 2150
2020
Q3 		$92K Buy
+19,010
New +$124K ﹤0.01% 2142

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Cliff Asness's AQST Position: Q2 2026 in Review

Cliff Asness increased its Aquestive Therapeutics (AQST) stake by 291% in Q2 2026, buying an estimated $633K and bringing the position to 201,941 shares worth $840K. The position accounts for ﹤0.01% of the portfolio, ranked #3103.

Cliff Asness first reported a position in AQST in Q3 2020 and has held it in 11 quarters since. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Cliff Asness held 201,941 shares of Aquestive Therapeutics worth $840K as of Q2 2026.
  • Cliff Asness bought 150,347 Aquestive Therapeutics shares in Q2 2026, an estimated $633K.
  • Aquestive Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3103 holding.
  • Cliff Asness first reported a position in Aquestive Therapeutics in Q3 2020 and has held it in 11 quarters since.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.